1. Stocks
    2. /
  2. Australian Clinical Labs Limited (ASX: ACL)
    3. /

Australian Clinical Labs Limited (ASX: ACL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Australian Clinical Labs Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Australian Clinical Labs Limited (ASX: ACL)
    Latest News

    Two children hold on tightly to books hugged against their chests, as if they were holding on to ASX shares for the long term.
    Investing Strategies

    16% dividend yield: Fund names 2 slammed ASX shares to buy for the long run

    | Tony Yoo

    If you're in a skittish market, then the trick is not to become skittish yourself. Here's a pair of quality…

    Read more »

    A young man clasps his hand to his head with a pained expression on his face and a laptop computer in front of him.
    Share Fallers

    Why ANZ, Australian Clinical Labs, Core Lithium, and Kogan are sinking today

    | James Mickleboro

    These ASX shares are sinking on Thursday...

    Read more »

    A man wearing a white coat and glasses is wide-mouthed in surprise.
    Healthcare Shares

    Another ASX All Ords share is plunging 12% on cyberattack news

    | James Mickleboro

    This pathology services provider has revealed that it was hit by a cyberattack in February...

    Read more »

    Two cute young children, a boy and a girl, sit on a sofa together with eager looks on their faces as the boy holds a remote control in one hand.
    Broker Notes

    'Bright outlook': Expert picks 2 ASX shares that touch Aussies everyday

    | Tony Yoo

    Brands that Australians use everyday can be a great place to start when coming up with stocks to invest in…

    Read more »

    A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
    Dividend Investing

    3 ASX All Ordinaries shares trading ex-dividend today

    | Cathryn Goh

    These shares are underperforming today. Here's why.

    Read more »

    Green arrow going up on stock market chart, symbolising a rising share price.
    Share Gainers

    Why Australian Clinical Labs, Lake Resources, PolyNovo, and ResApp are rising

    | James Mickleboro

    These ASX shares are pushing higher despite the market selloff...

    Read more »

    A group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
    Healthcare Shares

    Why these 3 ASX healthcare shares could get a boost from the federal budget

    | Brooke Cooper

    We check whether additional funding for COVID-19 testing might impact these ASX shares?

    Read more »

    A man wearing a white coat and glasses is wide-mouthed in surprise.
    Earnings Results

    Australian Clinical Labs (ASX:ACL) share price falls despite tripling profits and beating guidance

    | James Mickleboro

    This healthcare share had a strong half..

    Read more »

    A man with a wide, eager smile on his face holds up three fingers.
    Broker Notes

    Top broker just rated these 3 ASX shares as buys

    | Zach Bristow

    Here's a hint: all 3 have some exposure to COVID-19 testing.

    Read more »

    A stopwatch ticking close to the 12 where the words on the face say 'Time to Buy' indicating its the bottom of the falling market and time to buy ASX shares
    Opinions

    This top fund manager just called these leading ASX shares a buy

    | Tristan Harrison

    WAM thinks that these two ASX shares are buys.

    Read more »

    A man screws up his face as his nose is swabbed for a COVID test.
    Healthcare Shares

    2 ASX 200 shares benefitting from the surge in COVID tests

    | Tristan Harrison

    Sonic is one of the ASX shares benefiting from a high level of COVID testing.

    Read more »

    A health professional wearing green scrubs and a face mask and stethoscope uses his mobile phone.
    Healthcare Shares

    In the green: Here are the 5 best ASX healthcare shares of 2021

    | Zach Bristow

    ASX healthcare shares were a strong bunch last year, with several majors and minors outperforming the primary indices.

    Read more »

    Frequently Asked Questions

    Yes, Australian Clinical Labs has historically paid two fully franked shareholder dividends a year.

    Australian Clinical Labs generally pays its shareholder dividends in April and September.

    Australian Clinical Labs Ltd listed on the ASX on 14 May 2021.

    ACL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Australian Clinical Labs Limited

    Australian Clinical Labs Ltd (ASX: ACL) is a leading provider of pathology services in Australia. The company's 75 laboratories perform more than 12 million episodes annually with a network of more than 1,300 collection centres in every Australian state and territory except Tasmania. The company is also among the largest private hospital pathology businesses in the country, providing services to more than 90 private and public hospitals.

    Its services include all routine pathology tests, advanced pathology, pregnancy screening, non-invasive prenatal testing, chemical pathology, haematology, histopathology, immunology, serology and microbiology, and commercial drug and alcohol testing. 

    In ACL's established regions of Western Australia, Victoria, New South Wales, Queensland, South Australia, and the Northern Territory, the company has an equivalent market position in community pathology to its rivals Sonic Healthcare Ltd (ASX: SHL) and Healius Ltd (ASX: HLS). The company says it also has a growing presence in the Australian Capital Territory.

    Profile

    since

    Note